Most Medicare choices are made fast, then paid for slowly in the exam room
A January follow-up can reveal the whole problem at once: the medication list is unchanged, the symptoms are familiar, and the insurance card is not. A Medicare plan can move a drug to a higher tier, raise the deductible, or drop a long-trusted clinician from network without the patient noticing until the next refill or specialist visit. By then, the decision made during open enrollment is no longer an administrative errand. It has become a barrier to treatment.
A University of Michigan poll found that 60% of Medicare enrollees age 65 and older spent less than an hour choosing coverage during last year’s open enrollment. Within that group, 27% did not review their options at all, while 33% looked but spent less than an hour on the task. Eight in 10 kept the same coverage they had the year before.
That kind of inertia has direct clinical consequences. Coverage determines which doctors remain available, which prescriptions are affordable, and whether the front-desk balance becomes a delay in care. In primary care, cardiology, oncology, and nearly every other ambulatory specialty, insurance design now shapes adherence as much as diagnosis does.
Confidence is high while awareness stays low
The poll exposes a sharp gap between confidence and understanding. Ninety-two percent of respondents said they were somewhat or very confident making Medicare coverage decisions, yet awareness of the most important changes affecting their costs and access remained limited.
Only 38% had heard about lower prices on 10 high-cost drugs tied to Medicare’s new authority to negotiate with drugmakers. Fifteen more drugs are scheduled to join that list for 2027. At the same time, just 29% knew about two changes that increase patient exposure to drug costs: a higher Part D deductible and a higher annual out-of-pocket cap. The cap rises to $2,400 in 2027, up from $2,100 this year and $2,000 in 2025, while Part D deductibles can reach $700.
Even basic navigation remains difficult. Just 15% knew that Medicare’s Plan Finder tool can now show which physicians and other clinicians a Medicare Advantage plan places in network. For many patients, that feature is the difference between continuity and disruption. If a plan no longer includes the clinicians a patient sees most often, the consequences show up as referrals delayed, visits rescheduled, and coverage appeals that consume staff time.
Jeffrey Kullgren, M.D., M.P.H., M.S., who directs the poll, said respondents cared most about out-of-pocket costs, medication coverage, and whether their providers were in network. Those were ranked by 69%, 63%, and 62% of respondents, respectively. The irony is hard to miss: patients value the variables that require the most careful review, yet many spend little or no time checking them.
A second layer of uncertainty sits underneath all of this. Insurance companies change the Medicare Advantage and drug plans they sell, and they also change where they sell them. A plan that exists one year may be gone the next. In practical terms, a patient who assumes last year’s choice still fits may be carrying the wrong coverage into a new year’s clinical reality.
When coverage misses the chart, practices absorb the friction
Coverage mismatches do not stay confined to the billing office. They spill into treatment adherence, authorization work, and the tempo of care. Scott Woods, founder of Patient Coverage Connect, has argued that Medicare Advantage mismatches are a practice problem as much as a patient problem, because the administrative burden lands on physicians and staff when patients choose plans that do not match their care needs.
A poorly matched plan can mean an expensive prescription goes unfilled, a specialist visit is postponed, or a network dispute interrupts continuity with a physician a patient has seen for years. Those failures matter clinically because medication gaps and delayed follow-up can worsen chronic disease control, increase emergency department use, and generate avoidable cost. For practices, they also mean more prior authorizations, more denials, and more unpaid balances.
Plan exits deepen the strain. At least 25 health systems had cut ties with certain Medicare Advantage plans by 2026, and up to 1 in 10 Medicare Advantage enrollees face forced disenrollment when insurers discontinue plans. Patients often do not realize that the window to fix these problems is open during enrollment and narrow after it closes. Once January arrives, the consequences are already in the schedule.
A short, blunt sentence captures the clinical stakes: a missed review in October can become a missed refill in February.
Who patients trust, and where physicians can intervene without steering
The poll also explored where patients turn for help. Insurance brokers were the most common resource among those who reviewed options, named by 26%. Medicare’s own tools and hotline followed at 25%, and health plan websites came in at 21%. Only 5% named a State Health Insurance Assistance Program counselor as their most important source.
SHIP counselors are federally funded, operate in every state, and have no financial stake in the plan a patient chooses. That makes them a rare unbiased guide in a market where brokers are paid commissions by insurers for enrollments. Geoffrey Hoffman, Ph.D., who worked with the poll team, said older adults can easily settle into a “set it and forget it” approach with Medicare. He pointed to SHIP counselors as an underused resource.
Lianlian Lei, Ph.D., compared the Medicare decision to buying a car or a major appliance, but the analogy only goes so far. Coverage is not a one-time consumer purchase; it is an ongoing clinical filter. The right plan depends on current prescriptions, preferred physicians and hospitals, and health conditions that can change over a single year. A plan that works for one spouse may fail another person in the same household.
For practices, the most useful interventions are modest and concrete. A reminder at check-in or in the patient portal can prompt review before the Dec. 7 deadline. An updated medication list and a current list of the practice’s Medicare Advantage contracts give patients the inputs they need to use Plan Finder effectively. Posting the local SHIP contact information offers a neutral path to help for patients who do not want a broker’s sales pitch.
There is also a second chance. Patients who enroll in a Medicare Advantage plan and later regret it can switch to another MA plan or to traditional Medicare between Jan. 1 and March 31. Staff who hear about a surprise network exclusion or a failed pharmacy claim in January should know that the problem may still be reversible. Patients moving back to traditional Medicare also need to understand that Medigap underwriting rules vary by state.
The central clinical issue is not whether patients dislike paperwork. It is whether a rushed enrollment decision becomes a yearlong obstacle to care, with physicians left to absorb the administrative fallout.